
On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State Oils, Kingdom Harvest, Kahm CBD,…
On May 26, the Food and Drug Administration (FDA) sent warning letters to Free State Oils, Kingdom Harvest, Kahm CBD,…
In May 2022, the Digital Therapeutics Alliance released a report titled DTx Value Assessment & Integration Guide. This new report…
Whether directly or indirectly experienced, violence can have a negative impact on the health of individuals and communities. For example,…
In March 2020, the U.S. Food and Drug Administration (FDA) recognized the need for more data to address the gaps…
On May 19, 2022, the American Hospital Association (AHA) sent a letter to the Administrator of the Centers for Medicare…
When addressing the Food and Drug Administration’s (FDA) reluctancy to develop new regulations for cannabidiol (CBD), FDA Commissioner Robert Califf…
Some patients that have recovered from a COVID-19 infection experience what the CDC has termed “long-COVID”. Long-COVID is a condition…
In its 2023 Notice of Benefit and Payment Parameters Proposed Rule (2023 NBPP), the U.S. Department of Health and Human…
On April 13, the Food and Drug Administration published a draft guidance on “Diversity Plans to Improve Enrollment of Participants…
On April 5, 2022, the Biden Administration announced that the Treasury Department and the Internal Revenue Service (IRS) proposed a…